ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2463
0,01%
Bitcoin
67.699,00
-0,04%
Brent Oil
81,295
0,00%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. United Therapeutics Corporation (UTHR)

  7. United Therapeutics Corporation (UTHR) Notícias

UTHR

United Therapeutics (UTHR)

United Therapeutics Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:UTHR
DataHoraFonteTítuloCódigoCompanhia
31/05/202408:00Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:UTHRUnited Therapeutics Corporation
30/05/202417:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
14/05/202417:10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
01/05/202407:30Business WireUnited Therapeutics Corporation Reports First Quarter 2024 Financial ResultsNASDAQ:UTHRUnited Therapeutics Corporation
26/04/202415:02Business WireCORRECTING and REPLACING PHOTO United Therapeutics Announces World’s First Successful Xenothymokidney TransplantNASDAQ:UTHRUnited Therapeutics Corporation
24/04/202410:00Business WireUnited Therapeutics Announces World’s First Successful Xenothymokidney TransplantNASDAQ:UTHRUnited Therapeutics Corporation
24/04/202408:00Business WireUnited Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024NASDAQ:UTHRUnited Therapeutics Corporation
16/04/202408:00Business WireUnited Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International ConferenceNASDAQ:UTHRUnited Therapeutics Corporation
26/03/202408:00Business WireUnited Therapeutics Announces the First Comprehensive Review Publication on XenotransplantationNASDAQ:UTHRUnited Therapeutics Corporation
25/03/202408:00Business WireUnited Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase ProgramNASDAQ:UTHRUnited Therapeutics Corporation
05/03/202408:00Business WireUnited Therapeutics Corporation to Present at the Leerink Partners Global Biopharma Conference 2024NASDAQ:UTHRUnited Therapeutics Corporation
27/02/202408:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:UTHRUnited Therapeutics Corporation
27/02/202408:00Business WireUnited Therapeutics Corporation to Present at the TD Cowen 44th Annual Health Care ConferenceNASDAQ:UTHRUnited Therapeutics Corporation
21/02/202408:03Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:UTHRUnited Therapeutics Corporation
21/02/202408:00Business WireUnited Therapeutics Corporation Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:UTHRUnited Therapeutics Corporation
21/02/202407:55Business WireUnited Therapeutics Commences Litigation to Ensure Fairness in the Drug Review ProcessNASDAQ:UTHRUnited Therapeutics Corporation
14/02/202418:57Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:UTHRUnited Therapeutics Corporation
14/02/202408:00Business WireUnited Therapeutics Corporation to Report Fourth Quarter and Full Year 2023 Financial Results Before the Market Opens on Wednesday, February 21, 2024NASDAQ:UTHRUnited Therapeutics Corporation
29/12/202308:00Business WireUnited Therapeutics Corporation to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:UTHRUnited Therapeutics Corporation
22/12/202311:51Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:UTHRUnited Therapeutics Corporation
14/12/202316:06Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
13/12/202312:03Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:UTHRUnited Therapeutics Corporation
13/12/202311:15Business WireUnited Therapeutics and Miromatrix Medical Announce Completion of Tender Offer and MergerNASDAQ:UTHRUnited Therapeutics Corporation
12/12/202308:00Business WireUnited Therapeutics and Miromatrix Medical Announce Successful Tender OfferNASDAQ:UTHRUnited Therapeutics Corporation
07/12/202308:00Business WireUnited Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2024NASDAQ:UTHRUnited Therapeutics Corporation
13/11/202308:06Edgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:UTHRUnited Therapeutics Corporation
01/11/202317:50Edgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:UTHRUnited Therapeutics Corporation
01/11/202307:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:UTHRUnited Therapeutics Corporation
01/11/202307:00Business WireUnited Therapeutics Corporation Reports Third Quarter 2023 Financial ResultsNASDAQ:UTHRUnited Therapeutics Corporation
31/10/202307:05Business WireUnited Therapeutics Announces First Patient Enrolled in Phase 3 TETON PPF Study of Nebulized Tyvaso in Patients with Progressive Pulmonary FibrosisNASDAQ:UTHRUnited Therapeutics Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:UTHR

Seu Histórico Recente

LSE
14SM
Comw.bk.a.23
USOTC
FIGI
Freedom Internet (PK)
BIT
UV4M0C
UniCredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados